RodbardD: Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther, 2016; 18Suppl 2:S3–S13.
2.
ThabitH, HovorkaR: Coming of age: the artificial pancreas for type 1 diabetes. Diabetologia, 2016; 59:1795–1805.
3.
BergenstalRM, KlonoffDC, GargSK, et al.: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med, 2013; 369:224–232.
4.
HowsmonD, BequetteBW: Hypo- and hyperglycemic alarms: devices and algorithms. J Diabetes Sci Technol, 2015; 9:1126–1137.
5.
BuckinghamBA, RaghinaruD, CameronF, et al.: Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care, 2015; 38:1197–1204.
6.
Centers for Disease Control and Prevention. Diabetes Report Card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services, 2015.
7.
WoodJR, MillerKM, MaahsDM, et al.: Most youth with type 1 diabetes in the T1D exchange clinic registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care, 2013; 36:2035–2037.
8.
MillerKM, BeckRW, BergenstalRM, et al.: Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care, 2013; 36:2009–2014.
9.
GargSK, WeinzimerSA, TamborlaneWV, et al.: Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther, 2017; 19:155–163.
10.
BeckRW, RiddlesworthT, RuedyK, et al.: Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA, 2017; 317:371–378.
11.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, TamborlaneWV, BeckRW, et al.; Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359:1464–1476.
12.
BequetteBW: Challenges and recent progress in the development of a closed-loop artificial pancreas. Annu Rev Control, 2012; 36:255–266.
13.
HeinemannL, WeyerC, RauhausM, et al.: Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart. Diabetes Care, 1998; 21:1910–1914.
14.
ColbergSR, LaanR, DassauE, et al.: Physical activity and type 1 diabetes: time for a rewire?. J Diabetes Sci Technol, 2015; 9:609–618.
15.
Diabetes Research in Children Network Study G, TsalikianE, KollmanC, et al.: Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care, 2006; 29:2200–2204.
